Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01414803
What this trial is testing

Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia

Who this might be right for
Hyperlipidemia
Yonsei University 180
Not applicableStudy completedNCT05764317
What this trial is testing

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

Who this might be right for
Arterial HypertensionHTN
Servier Russia 409
Not applicableStudy completedNCT05642221
What this trial is testing

Functional Near-Infrared Spectroscopy (fNIRS) Combined With Diffuse Correlation Spectroscopy (DCS) in Neurocognitive Disease as Compared to Healthy Neurotypical Controls

Who this might be right for
Juvenile Neuronal Ceroid LipofuscinosisSmith-Lemli-Opitz SyndromeCreatine Transporter Deficiency+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 73
Post-approval studies (Phase 4)Study completedNCT03847506
What this trial is testing

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

Who this might be right for
Hypertension, Hyperlipidemia
HK inno.N Corporation 127
Large-scale testing (Phase 3)Ended earlyNCT00267280
What this trial is testing

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

Who this might be right for
HyperlipidemiaDyslipidemiaHypercholesterolemia
Pfizer 640
Post-approval studies (Phase 4)Study completedNCT02772640
What this trial is testing

Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

Who this might be right for
Hypercholesterolemia
Collegium Medicum w Bydgoszczy 83
Not applicableStudy completedNCT00002417
What this trial is testing

Amprenavir in Patients With Protease Inhibitor-Related Complications

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT04783714
What this trial is testing

Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults

Who this might be right for
Hypercholesterolemia
Swisse Wellness Pty Ltd 42
Large-scale testing (Phase 3)Study completedNCT02166814
What this trial is testing

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Who this might be right for
Essential Hypertension, Dyslipidemia
Boryung Pharmaceutical Co., Ltd 140
Post-approval studies (Phase 4)Study completedNCT00249938
What this trial is testing

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Who this might be right for
HyperlipidemiaDyslipidemia
University of Colorado, Denver 60
Large-scale testing (Phase 3)Study completedNCT00463606
What this trial is testing

Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
AstraZeneca 760
Large-scale testing (Phase 3)Study completedNCT03103256
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

Who this might be right for
Hypertension and Hyperlipidemia
Yuhan Corporation 106
Large-scale testing (Phase 3)Ended earlyNCT00288483
What this trial is testing

Cholesterol-Lowering Effects of Policosanol

Who this might be right for
HypercholesterolemiaCombined Hyperlipidemia
Drug Commission of the German Medical Association
Not applicableStudy completedNCT02481466
What this trial is testing

The Combined Portfolio Diet and Exercise Study

Who this might be right for
Cardiovascular DiseasesHypercholesterolemiaType 2 Diabetes+1 more
Unity Health Toronto 232
Not applicableStudy completedNCT01555294
What this trial is testing

Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification

Who this might be right for
Cardiovascular Disease
Radboud University Medical Center 1,960
Large-scale testing (Phase 3)Study completedNCT00903409
What this trial is testing

Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 188
Large-scale testing (Phase 3)Study completedNCT00143234
What this trial is testing

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

Who this might be right for
HypertensionHyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,825
Not applicableStudy completedNCT05750602
What this trial is testing

Combined Effect of LIMICOL and Physical Activity on LDL Cholesterol and Muscle Function.

Who this might be right for
Hypercholesterolemia
Lescuyer Laboratory 40
Large-scale testing (Phase 3)Study completedNCT00349284
What this trial is testing

A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome

Who this might be right for
Hyperlipidemia Combined
Solvay Pharmaceuticals 181
Testing effectiveness (Phase 2)Study completedNCT01380730
What this trial is testing

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Who this might be right for
Hyperlipidemia
Amgen 631
Next Page